Success Stories: Nebraska Service Center Approves EB-1A of Research Investigator from China in the Field of Biomedical Engineering
Client’s Testimonial:
“Thanks for your email, and thanks for preparing the case for me.”
On March 7th, 2017, we received another EB-1A (Alien of Extraordinary Ability) approval for a Research Investigator in the Field of Biomedical Engineering (Approval Notice).
General Field: Biomedical Engineering
Position at the Time of Case Filing: Research Investigator
Country of Origin: China
Service Center: Nebraska Service Center (NSC)
State of Residence at the Time of Filing: California
Approval Notice Date: March 7th, 2017
Processing Time: 20 Days (Premium Processing Requested)
Case Summary:
Roughly 3 months after North America Immigration Law Group (NAILG) filed an EB-1A (Alien of Extraordinary Ability) petition on behalf of a Chinese research investigator, NSC approved his case. Our client elected to upgrade his case to Premium Processing, which greatly reduced the overall wait time for a decision (it usually takes the USCIS between 4-9 months to adjudicate I-140 petitions).
With a Ph.D. in Materials Science and Engineering, our client is proficient in carrying out research in the field of biomedical engineering. His studies have propelled him to the top of the field and he has sustained international/national influence. In order to prove this to the USCIS, we demonstrated that he met at least 3 of the 10 evidentiary criteria for EB1A. The 3 criteria we focused on were (1) original contributions, (2) authorship, and (3) judge the work of others. At the time of filing, our client’s work had already collected 173 citations, he had authored and published 13 scientific articles and 2 book chapters, and he had judged the work of his peers on 50 occasions.
Besides that, we urged our client to gather external support from his peers in the form of recommendation letters. These letters backed up our arguments in the EB1A petition and substantially proved that our client’s efforts in developing biomaterials and tissue engineering strategies are important to the US. This is a quote taken from one of these letters: “Through his research, he developed two methods to enhance the effectiveness of stem cell therapy for immune-mediated inflammatory diseases. This work greatly contributes to improving public health in the U.S.”
We congratulate our client for securing EB1A petition approval, and we thank him for choosing us to represent his case.